Abeona Therapeutics Statistics
NASDAQ: ABEOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.08+0.07 (+1.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Abeona Therapeutics by the numbers
Abeona Therapeutics has a market capitalization of $290.5 million based on 57.18M shares outstanding. With trailing EPS of $-1.18, Abeona Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.7% below its 50-day average and 8.5% below its 200-day average.
Average daily trading volume is 1.42M shares, or about $7.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABEO valuation vs. peer median
| Metric | ABEO | Peer median | Difference |
|---|---|---|---|
| Market cap | $290.49M | $280.41M | +4% |
| Avg. volume | 1.42M | 1.14M | +24% |
Peer median across 8 companies: LRMR, BIOA, CATX, FULC, RCKT, BBOT, VNDA, INDP.
Valuation
- Market cap
- $290.49M
- EPS (TTM)
- $-1.18
- Shares outstanding
- 57.18M
Price and trading
- Previous close
- 5.01
- Open
- 4.95
- Day range
- 4.94 – 5.10
- 52-week range
- 4.00 – 7.65
- 52-week change
- -3.24%
- Beta
- —
- Volume
- 736.72K
- Average volume
- 1.42M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 290.49M
- Forward Pe
- -24.48
- Eps
- -1.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.65
- Week52 Low
- 4.00
- Avg Volume
- 1.42M
- Shares Outstanding
- 57.18M
- Ma50
- 5.96
- Ma200
- 5.55
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -33.59%
- Pct From52w Low
- 27.00%